These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2979315)

  • 1. A function for inososes in mammalian tissue: inhibition of D-xylose: NADP 1-oxidoreductase and its analytical use for discrimination of inositols and inososes.
    Logemann E; Wissler JH
    Acta Med Leg Soc (Liege); 1985; 35(2):184-8. PubMed ID: 2979315
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of lens aldose reductase by Labiatae flavonoids.
    Tomás-Barberán FA; López-Gómez C; Villar A; Tomás-Lorente F
    Planta Med; 1986 Jun; (3):239-40. PubMed ID: 3092256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition of aldose reductase from the rat lens by flavonoids].
    Xie MZ; Shen ZF
    Yao Xue Xue Bao; 1986 Oct; 21(10):721-4. PubMed ID: 3107341
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of lens-aldose reductase activity by brazilin and haematoxylin.
    Moon CK; Yun YP; Lee JH; Wagner H; Shin YS
    Planta Med; 1985 Feb; (1):66-7. PubMed ID: 3925476
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S; Simmons DA; Kern EF
    Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible aldose reductase inhibitors.
    Kador PF; Gurley RC; Ares JJ; Miller DD
    Prog Clin Biol Res; 1987; 232():353-65. PubMed ID: 3112788
    [No Abstract]   [Full Text] [Related]  

  • 8. [The activity of xylose reductase and xylitol dehydrogenase in yeasts].
    Iablochkova EN; Bolotnikova OI; Mikhaĭlova NP; Nemova NN; Ginak AI
    Mikrobiologiia; 2003; 72(4):466-9. PubMed ID: 14526534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibition by anti-allergy drugs.
    Kador PF; Sharpless NE; Goosey JD
    Prog Clin Biol Res; 1982; 114():243-59. PubMed ID: 6131432
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacophor requirements of the aldose reductase inhibitor site.
    Kador PF; Sharpless NE
    Mol Pharmacol; 1983 Nov; 24(3):521-31. PubMed ID: 6415401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductases from human retina and bovine lens: dependence of inhibition upon the choice of enzyme substrate.
    Poulsom R
    Prog Clin Biol Res; 1987; 232():341-52. PubMed ID: 3112787
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic mechanism and structural properties of lens aldose reductase.
    Doughty CC; Lee SM; Conrad S; Schade S
    Prog Clin Biol Res; 1982; 114():223-42. PubMed ID: 6819583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis and pharmacologic study of several spirohydantoins: relation to conformation].
    Courtoison JC; Coudert P; Couquelet J; Tronche P; Jonadet M; Bastide P
    Farmaco Sci; 1988 Feb; 43(2):153-60. PubMed ID: 3134252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altering the course of cataracts in diabetic rats.
    Fukushi S; Merola LO; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic cataracts- is aldose reductase important?
    Crabbe MJ; Wolff S; Halder AB; Ting HH
    Metab Pediatr Ophthalmol; 1981; 5(1):33-8. PubMed ID: 6789018
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activity of the key enzymes in xylose-assimilating yeasts at different rates of oxygen transfer to the fermentation medium].
    Iablochkova EN; Bolotnikova OI; Mikhaĭlova NP; Nemova NN; Ginak AI
    Mikrobiologiia; 2004; 73(2):163-8. PubMed ID: 15198025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical spectroscopy as an in vitro method to monitor aldose reductase inhibitors in the lens.
    Lerman S; Megaw J; Gardner K
    Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1505-10. PubMed ID: 6417041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.